(주)에피바이오텍

{
  "address": "인천 연수구",
  "ceo_name": "성종혁",
  "certificate": [
    {
      "cert_number": "20160300323",
      "changes": "",
      "disclosure_date": "2016-07-07",
      "first_cert_date": "2016-07-07",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2016-07-07 ~ 2018-07-06"
    },
    {
      "cert_number": "20180300662",
      "changes": "",
      "disclosure_date": "2018-09-20",
      "first_cert_date": "2016-07-07",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2018-09-20 ~ 2020-09-19"
    },
    {
      "cert_number": "20200301149",
      "changes": "",
      "disclosure_date": "2020-10-08",
      "first_cert_date": "2016-07-07",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2020-09-20 ~ 2022-09-19"
    },
    {
      "cert_number": "20220921010015",
      "changes": "",
      "disclosure_date": "2022-09-21",
      "first_cert_date": "2016-07-07",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2022-09-20 ~ 2025-09-19"
    },
    {
      "cert_number": "20250924010015",
      "changes": "",
      "disclosure_date": "2025-09-24",
      "first_cert_date": "2016-07-07",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2025-09-20 ~ 2028-09-19"
    }
  ],
  "company_name": "주식회사 에피바이오텍",
  "corp_no": "120111-*******",
  "financials": {
    "2022": {
      "capital_stock": 1506814000,
      "cost_of_sales": 139972000,
      "current_assets": 3734822000,
      "current_liabilities": 2731935000,
      "gross_profit": 260149000,
      "net_income": -5256977000,
      "net_income_bs": -5256977000,
      "non_current_assets": 5561993000,
      "non_current_liabilities": 259840000,
      "non_operating_expenses": 140651000,
      "non_operating_income": 170748000,
      "operating_profit": -5287074000,
      "revenue": 400121000,
      "sga_expenses": 5547222000,
      "total_assets": 9296815000,
      "total_equity": 6305040000,
      "total_liabilities": 2991775000
    },
    "2023": {
      "capital_stock": 1509314000,
      "cost_of_sales": 208663000,
      "current_assets": 998441000,
      "current_liabilities": 3032818000,
      "gross_profit": 267696000,
      "net_income": -3884184000,
      "net_income_bs": -3884183000,
      "non_current_assets": 4787359000,
      "non_current_liabilities": 276600000,
      "non_operating_expenses": 246666000,
      "non_operating_income": 987275000,
      "operating_profit": -4624793000,
      "revenue": 476359000,
      "sga_expenses": 4892489000,
      "total_assets": 5785800000,
      "total_equity": 2476382000,
      "total_liabilities": 3309418000
    },
    "2024": {
      "capital_stock": 1509314000,
      "cost_of_sales": 213186000,
      "current_assets": 834780000,
      "current_liabilities": 1838987000,
      "gross_profit": 533554000,
      "net_income": -1726143000,
      "net_income_bs": -1726142000,
      "non_current_assets": 1971175000,
      "non_current_liabilities": 72020000,
      "non_operating_expenses": 252639000,
      "non_operating_income": 1491561000,
      "operating_profit": -2965065000,
      "revenue": 746739000,
      "sga_expenses": 3498618000,
      "total_assets": 2805954000,
      "total_equity": 894947000,
      "total_liabilities": 1911007000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "850,000,000",
      "changes": "850,000,000",
      "date": "2025-04-24"
    },
    {
      "amount": "2,986,000,000",
      "changes": "2,986,000,000",
      "date": "2021-01-26"
    },
    {
      "amount": "1,760,000,000",
      "changes": "1,760,000,000",
      "date": "2021-01-26"
    },
    {
      "amount": "1,444,000,000",
      "changes": "1,444,000,000",
      "date": "2021-01-26"
    },
    {
      "amount": "1,999,000,000",
      "changes": "1,999,000,000",
      "date": "2019-04-29"
    },
    {
      "amount": "350,000,000",
      "changes": "350,000,000",
      "date": "2018-07-10"
    }
  ],
  "main_products": "탈모 치료제,바이오약품 개발,공급",
  "phone": "070-4209-****",
  "years": [
    2024,
    2023,
    2022
  ]
}